相关实验视频
Updated: Jun 28, 2025

03:26
Detrusor Underactivity Model in Rats by Conus Medullaris Transection
Published on: August 28, 2020
2.0K
多发性硬化症的空白期功能障碍:术语,诊断,管理和未来方向的当代审查
Catherine Frances Ingram1, John A Lincoln2, Rose Khavari3
1Department of Urology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
The Urologic clinics of North America
|April 12, 2024
概括
下尿道症状 (LUTS) 在多发性硬化症 (MS) 中很常见. 泌尿动力学研究有助于诊断患有MS的男性持续性LUTS,新的治疗方法需要进一步研究.
科学领域:
- 神经学 神经学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 下尿路症状 (LUTS) 在多发性硬化症 (MS) 患者中非常普遍.
- 目前在MS中对LUTS的评估方法可能不足,因为定义模糊或缺乏对无症状个体的查.
- 尿的非神经性定义需要在MS患者群体中仔细考虑.
研究的目的:
- 突出在MS患者中评估LUTS的挑战.
- 强调尿动力学研究对于诊断男性多发性硬化症患者治疗耐药性LUTS的有用性.
- 确定未来对国家/地区LUTS管理的研究领域.
主要方法:
- 对手稿中关于LUTS的当前文献的综述.
- 讨论诊断方法,包括尿动力学研究.
- 探索现有和新兴的治疗方案.
主要成果:
- 模糊的定义和缺乏查使得成员国的LUTS评估变得复杂.
- 泌尿动力学研究对于识别MS男性持续性,耐治疗性LUTS的原因至关重要.
- 许多疗法存在,但新兴的治疗方法,如皮肤穿神经刺激和非侵入性脑刺激等,需要进一步研究.
结论:
- 准确的评估和诊断对于在MS中管理LUTS至关重要.
- 泌尿动力学研究为LUTS在受影响男性的病因提供了有价值的见解.
- 需要对新型治疗策略进行进一步的研究,以改善MS患者的LUTS管理.
相关概念视频
The Micturition Reflex
584
Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
584
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Irritable Bowel Syndrome III: Medical and Nursing Management
198
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
198
Urinary Bladder
655
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
655
Drugs for Treatment of Diarrhea-Predominant IBS
163
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
163
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
159
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
159

